BUY RPG Life Sciences Limited — Pankaj Pandey, ICICI Securities

Entry₹2,656.8Inferred
Target₹3,300
Total upside +24.21%
Stop lossNot given
CMP₹2,780.27h ago
Active+4.64%+18.70%upside left 10 mo left

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 11:24 pm IST
13 supporting4 neutral0 opposing
Supports the BUY call (13)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·22 Oct · today

RPG Life Sciences Ltd announced the completion of the acquisition of Actis Generics Private Limited. Actis is now a subsidiary of RPG Life Sciences and a wholly-owned subsidiary of RPG Active Pharma L

BSE · Company Update·24 Sept · 4w ago

(opens in new tab)

1 other SEBI-registered advisor has an active long-term BUY call on this stock

Advisor consensus · same horizon·4 Sept · 2mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.